Filter
37
Filtered Results: 37
Text search:
García-Mingo,
A.
Featured
Recommendations
5
New Publications
9
Language
Document type
No document type
19
Studies & Reports
9
Guidelines
5
Manuals
2
Strategic & Response Plan
1
Fact sheets
1
Countries / Regions
Philippines
3
Venezuela
3
Latin America and the Carribbean
3
Brazil
3
Global
2
Russia
2
Colombia
1
Mozambique
1
Africa
1
Guinea-Bissau
1
Germany
1
West and Central Africa
1
Middle East and North Africa
1
Paraguay
1
North America
1
East and Southern Africa
1
Bolivia
1
Vietnam
1
Angola
1
India
1
Authors & Publishers
Publication Years
Category
COVID-19
7
Studies & Reports
6
Guidelines
5
Under-5 nutrition
1
Disabilities
1
Yersinia pestis (Plague)
1
Chagas
1
Statistics
1
Maternal Health
1
Non-communicable Diseases
1
Disease Prevention & Control
1
TB
1
Toolboxes
Clinical Guidelines
5
Country specific documents
3
Global Impact: Socio-economic, health services, TB & HIV
2
Africa
1
ART Drug Resistance
1
Prevention & Control
1
Substance Use Disorders, Others
1
Africa
1
General Studies & Reports
1
IACAPAP International Association for Child and Adolescent Psychiatry and Allied Professions
1
Epilepsy
1
International
1
Context & Facts, Travel Advice
1
HIV and COVID-19
1
COVID-19
1
Long COVID/ Post-COVID Syndrome
1
Traditional & Herbal Medicines
1
Epilepsy
1
Chagas
1
Clinical Aspects & Diagnostics
1
Statistics & Facts
1
Studies & Reports
1
Overview, Studies & Reports
1
Taeniasis/Cysticercosis
1
Access to treatment and laboratory
1
Clinical Aspects & Diagnosis
1
Neurological Disorders
1
Substance Use Disorders & Addiction
1
National Emergency Response Plans
1
Western & Central Europe
1
Eastern Europe & Central Asia
1
Plague Prevention & Control
1
Research and Reports in Tropical Medicine 2022:13 25–40
Chagas disease (CD) or American trypanosomiasis is a neglected parasitic disease associated with significant mortality and morbidity that includes long-term disability, social stigma and a mental health toll. Perceived as a disease of the ve...
Chagas disease (CD) is caused by the parasite Trypanosoma cruzi, and it is endemic in Central, South America, Mexico and the
South of the United States. It is an important cause of early mortality and morbidity, and it is associated with poverty and stigma. A third of
the cases evolve into chronic...
The document "Chronic Respiratory Diseases: A Handbook for Pharmacists" outlines the significant role pharmacists play in managing asthma and COPD, emphasizing patient education, disease prevention, medication management, and promoting healthy lifestyles. It highlights the importance of pharmacists ...
Рекомендации ВОЗ по оказанию дородовой помощи для формирования положительного опыта беременности
www.jogh.org • doi: 10.7189/jogh.02.020405 ~ December 2012 • Vol. 2 No. 2 • 020405
Taenia saginata is a zoonotic tapeworm that is of economic importance in countries where cattle are kept. The parasite is transmitted from human tapeworm carriers (taeniosis) to bovines (cysticercosis) by excretion of eggs or proglottids containing eggs into the environment via the stool. Bovines ca...
The epidemiology of the disease is mediated by the interaction of the parasite (trypanosome) with the vectors (tsetse flies), as well as with the human and animal hosts within a particular environment. Related to these interactions, the disease is confined in spatially limited areas called “foci...
A discussion paper outlining the first steps in developing a nutrient profile model to drive changes to product composition and labelling and promotion practices in the WHO European Region
The aims of the guidance are to protect breastfeeding, prevent obesity and chronic diseases, promote a healthy...
Division of Noncommunicable Diseases | draft guidelines on diagnosis and management of a chronic immune-mediated enteropathy called celiac disease. This disease is caused is mainly caused in genetically susceptible individuals by ingestion of gluten proteins that are present in wheat, barley and oat...
The Global Burden of Disease (GBD) study, a collaborative endeavour of the World
Health Organization (WHO), the World Bank and the Harvard School of Public Health,
drew the attention of the international health community to the burden of neurological
disorders and many other chronic conditions. T...
Результаты исследования «Изучение распространенности коронавирусной инфекции COVID-19 среди инфицированных ВИЧ пациентов вРоссии ивлияния эпидемии коронавирусной...
WHO Living guideline: Drugs to prevent COVID-19
recommended
Interim guidance 2 march 2021
Current use of drugs to prevent COVID-19 is variable, reflecting large-scale uncertainty. Numerous randomized trials of many different drugs are underway to inform practice. This first version of the Drugs to prevent COVID-19: A WHO living guideline contains new inform...
Esta primeira versão de Medicamentos para prevenção da COVID-19: Orientação dinâmica da OMS aborda o uso de hidroxicloroquina para prevenção da COVID-19. Segue-se a publicação de uma análise sistemática e NMA que reuniu dados de seis estudos com 6.059 participantes que não tinham COVID-...
Resumo: o que é esta orientação dinâmica?
Pergunta clínica: qual é o papel dos medicamentos na prevenção da COVID-19?
Público-alvo: o público-alvo são os médicos e os tomadores de decisão na área da saúde.
Prática atual: o uso atual de medicamentos para prevenção da COVID-19 é ...
Stand 2.10.2020
Síndromes paralíticos, parálisis cerebral, down, trastorno del espectro autista, parkinson y discapacidad mental o psíquica
Serie Documentos Técnico Normativos 442
